ImmuTune IMP731
GSK signs £64m autoimmune antibody deal
January 7, 2011Research and Development GSK, GlaxoSmithKline, ImmuTune IMP731, Immutep, autoimmune diseases
GlaxoSmithKline has signed a worldwide licence agreement for a novel antibody designed to treat autoimmune diseases.The company will pay up …
Latest content
Highlighting the value of lab research for healthcare innovation
November 2, 2026
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
